• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

VA appoints 1st director of AI, plans to expand AI research: 4 notes

Share:

July 16, 2019

The Department of Veterans Affairs announced July 10 the appointment of Gil Alterovitz, PhD, as its first director of artificial intelligence, a position that will be based in the VA’s Office of Research and Development.

Here are four things to know about the appointment:

1. Dr. Alterovitz is a professor at Harvard Medical School and serves on the faculty of the Computational Health Informatics Program at Boston Children’s Hospital.

2. He helped write the White House’s updated strategic plan for AI research and development released earlier this year, and received a Federal 100 award for his efforts in “getting government ready for AI.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

3. Dr. Alterovitz’s work at the VA will focus on using big data and AI to reduce costs and improve the quality of care for veterans. He has already launched a “sprint” to find partner organizations to apply AI technology to the VA’s data.

4. The VA began implementing AI into its workflow years ago: The technology has so far been used to reduce appointment wait times, identify suicide risk from medical records and interpret cancer lab results to suggest the best treatments.

Date: July 16, 2019

Source: Becker’s Hospital Review

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • RK Pharma Completes Acquisition of VGYAAN Pharmaceuticals.RK Pharma Completes Acquisition of VGYAAN Pharmaceuticals.
  • City of Milwaukee Taps NowPow to Improve Health Equity & OutcomesCity of Milwaukee Taps NowPow to Improve Health Equity & Outcomes
  • AI in healthcare – not so fast? Study outlines challenges, dangers for machine learningAI in healthcare – not so fast? Study outlines challenges, dangers for machine learning
  • NewLink Genetics Stockholders Approve Merger with Lumos PharmaNewLink Genetics Stockholders Approve Merger with Lumos Pharma
  • Proscia & Hamamatsu Partner to Accelerate Scaled Adoption of Digital PathologyProscia & Hamamatsu Partner to Accelerate Scaled Adoption of Digital Pathology
  • Quit Genius Expands Addiction Treatment Program to Include Alcohol and OpioidsQuit Genius Expands Addiction Treatment Program to Include Alcohol and Opioids
  • CYduct Diagnostics, Inc. Completes Strategic AcquisitionCYduct Diagnostics, Inc. Completes Strategic Acquisition
  • CannaOne Technologies Enters into an Agreement to Acquire 100% Ownership of Real Life Sciences Inc., and the BWell US CBD MarketplaceCannaOne Technologies Enters into an Agreement to Acquire 100% Ownership of Real Life Sciences Inc., and the BWell US CBD Marketplace

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications